KMPharmaceutical Co Ltd (225430) Stock Price & News

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	4.38B	4.29B	4.47B	3.84B
Cost of goods sold	3.03B	3.41B	3.55B	3.22B
Cost of revenue	3.03B	3.41B	3.55B	3.22B
Research and development expenses	-	270.83M	138.25M	152.92M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.16B	1.72B	1.29B	993.59M
Operating expense	2.16B	1.93B	1.76B	1.38B
Total operating expenses	5.19B	5.33B	5.30B	4.60B
Operating income	-809.28M	-1.04B	-835.90M	-764.49M
Other non operating income	-135.33M	47.58M	6.13M	7.60M
EBT including unusual items	-1.02B	-1.08B	-834.16M	-756.69M
EBT excluding unusual items	-944.61M	-1.43B	-834.16M	-753.11M
Income tax expense	-	84.19M	-	-
Effective tax rate	-	-7.79%	-	-
Other operating expenses	-	15.24M	14.66M	13.25M
Net income	-1.02B	-1.16B	-834.16M	-756.69M
Net profit margin	-23.20%	-27.13%	-18.67%	-19.72%
Earnings per share	-	-	-	-
Interest and investment income	-	155.60M	242.77M	179.20M
Interest expense	-	-150.91M	-160.60M	-171.33M
Net interest expenses	-	4.69M	82.18M	7.87M
Depreciation and amortization charges	-	-177.94M	95.74M	75.93M
EBITDA	-569.43M	-803.59M	-612.30M	-564.68M
Gain or loss from assets sale	-	2.00K	-	3.58M

Finance